Literature DB >> 7883961

Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse.

Y Osono1, L A Woollett, J Herz, J M Dietschy.   

Abstract

These studies were undertaken to quantify cholesterol balance across the plasma space and the individual organs of the mouse, and to determine the role of the low density lipoprotein receptor (LDLR) in these two processes. In the normal mouse (129 Sv), sterol was synthesized at the rate of 153 mg/d per kg body weight of which 78% occurred in the extrahepatic tissues while only 22% took place in the liver. These animals metabolized 7.1 pools of LDL-cholesterol (LDL-C) per day, and 79% of this degradation took place in the liver. Of this total turnover, the LDLR accounted for 88% while the remaining 12% was receptor independent. 91% of the receptor-dependent transport identified in these animals was located in the liver while only 38% of the receptor-independent uptake wsa found in this organ. When the LDLR was deleted, the LDL-C production rate increased 1.7-fold, LDL-C turnover decreased from 7.1 to 0.88 pools/d, and the plasma LDL-C level increased 14-fold, from 7 to 101 mg/dl. Despite these major changes in the circulating levels of LDL-C, however, there was no change in the rate of cholesterol synthesis in any extrahepatic organ or in the whole animal, and, further, there was no change in the steady-state cholesterol concentration in any organ. Thus, most extrahepatic tissues synthesize their daily sterol requirements while most LDL-C is returned directly to the liver. Changes in LDLR activity, therefore, profoundly alter the plasma LDL-C concentration but have virtually no affect on cholesterol balance across any extrahepatic organ, including the brain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883961      PMCID: PMC441449          DOI: 10.1172/JCI117760

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.

Authors:  K H Weisgraber; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

Review 2.  Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans.

Authors:  J M Dietschy; S D Turley; D K Spady
Journal:  J Lipid Res       Date:  1993-10       Impact factor: 5.922

3.  Psyllium augments the cholesterol-lowering action of cholestyramine in hamsters by enhancing sterol loss from the liver.

Authors:  S D Turley; B P Daggy; J M Dietschy
Journal:  Gastroenterology       Date:  1994-08       Impact factor: 22.682

4.  Developmental and age-related changes in apolipoprotein B mRNA editing in mice.

Authors:  K Higuchi; K Kitagawa; K Kogishi; T Takeda
Journal:  J Lipid Res       Date:  1992-12       Impact factor: 5.922

5.  Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.

Authors:  S Ishibashi; M S Brown; J L Goldstein; R D Gerard; R E Hammer; J Herz
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

6.  Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance.

Authors:  T E Willnow; J L Goldstein; K Orth; M S Brown; J Herz
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

7.  Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools.

Authors:  C M Daumerie; L A Woollett; J M Dietschy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

8.  Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist.

Authors:  T E Willnow; Z Sheng; S Ishibashi; J Herz
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

9.  High prevalence of familial defective apolipoprotein B-100 in Switzerland.

Authors:  A R Miserez; R Laager; N Chiodetti; U Keller
Journal:  J Lipid Res       Date:  1994-04       Impact factor: 5.922

10.  Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor.

Authors:  J Herz; U Hamann; S Rogne; O Myklebost; H Gausepohl; K K Stanley
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  69 in total

1.  Multiple mechanisms limit the accumulation of unesterified cholesterol in the small intestine of mice deficient in both ACAT2 and ABCA1.

Authors:  Stephen D Turley; Mark A Valasek; Joyce J Repa; John M Dietschy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-19       Impact factor: 4.052

2.  Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene.

Authors:  H Shimano; I Shimomura; R E Hammer; J Herz; J L Goldstein; M S Brown; J D Horton
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  A single common portal for clathrin-mediated endocytosis of distinct cargo governed by cargo-selective adaptors.

Authors:  Peter A Keyel; Sanjay K Mishra; Robyn Roth; John E Heuser; Simon C Watkins; Linton M Traub
Journal:  Mol Biol Cell       Date:  2006-07-26       Impact factor: 4.138

4.  High density lipoprotein metabolism in low density lipoprotein receptor-deficient mice.

Authors:  Franz Rinninger; Markus Heine; Roshni Singaraja; Michael Hayden; May Brundert; Rajasekhar Ramakrishnan; Joerg Heeren
Journal:  J Lipid Res       Date:  2014-06-22       Impact factor: 5.922

5.  Effect of dietary cholesterol on low density lipoprotein-receptor, 3-hydroxy-3-methylglutaryl-CoA reductase, and low density lipoprotein receptor-related protein mRNA expression in healthy humans.

Authors:  P Boucher; M de Lorgeril; P Salen; P Crozier; J Delaye; J J Vallon; A Geyssant; R Dante
Journal:  Lipids       Date:  1998-12       Impact factor: 1.880

6.  Absence of an effect of vitamin E on protein and lipid radical formation during lipoperoxidation of LDL by lipoxygenase.

Authors:  Douglas Ganini; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2014-08-01       Impact factor: 7.376

7.  GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice.

Authors:  Hao Li; Stephen D Turley; Benny Liu; Joyce J Repa; John M Dietschy
Journal:  J Lipid Res       Date:  2008-04-30       Impact factor: 5.922

8.  Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid.

Authors:  Benny Liu; Charina M Ramirez; Anna M Miller; Joyce J Repa; Stephen D Turley; John M Dietschy
Journal:  J Lipid Res       Date:  2009-11-18       Impact factor: 5.922

9.  PRD125, a potent and selective inhibitor of sterol O-acyltransferase 2 markedly reduces hepatic cholesteryl ester accumulation and improves liver function in lysosomal acid lipase-deficient mice.

Authors:  Adam M Lopez; Jen-Chieh Chuang; Kenneth S Posey; Taichi Ohshiro; Hiroshi Tomoda; Lawrence L Rudel; Stephen D Turley
Journal:  J Pharmacol Exp Ther       Date:  2015-08-17       Impact factor: 4.030

10.  Bile acid and sterol metabolism with combined HMG-CoA reductase and PCSK9 suppression.

Authors:  Rex A Parker; Ricardo Garcia; Carol S Ryan; Xiaoqin Liu; Petia Shipkova; Valentin Livanov; Pritesh Patel; Siew P Ho
Journal:  J Lipid Res       Date:  2013-04-24       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.